Drug Trial Radar · NCT06660290
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
Last checked: Nov 20, 2026Latest source record: Mar 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55
Actual
Start
Jan 15, 2025
Primary completion
Feb 6, 2025
Study completion Feb 6, 2025
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Oct 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the percentage of ocular adverse events reported in subjects with dry eye disease (DED) between the intervention arm (0.003% AR-15512) and control arm (REFRESH® Classic).
Conditions
- Dry Eye Disease
Interventions
0.003% AR-15512 ophthalmic solutionDrug
Investigational ophthalmic solution administered topically in 4 different instillation variations: 512-RT (0.003% AR-15512 instilled at room temperature, eyes to remain open post-drop instillation); 512-COLD (0.003% AR-15512 stored in refrigerator and instilled immediately after removal from refrigerator, eyes to remain open post-drop instillation); 512-RT-EC (0.003% AR-15512 instilled at room temperature followed by subjects immediately closing their eyes); and 512-COLD-EC (0.003% AR-15512 stored in refrigerator and instilled immediately after removal from refrigerator followed by subjects immediately closing their eyes).
Artificial tearsDrug
Commercially available, preservative-free lubricant eye drops administered topically
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With Ocular Treatment-Emergent Adverse Events Attributed to Study InterventionTime frame: Up to Day 1 post drop instillation
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Eye Research Foundation
Newport Beach, California
Vision Institute
Colorado Springs, Colorado
Andover Eye Associates
Andover, Massachusetts
Total Eye Care, PA
Memphis, Tennessee
Advancing Vision Research, LLC
Smyrna, Tennessee
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.